RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe ...

Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi's Universal Immune ...

Flu season is here and a covid uptick is around the corner. Two infectious diseases experts offer their tips on how to plan for vaccination against those viruses.

What sets Imunon's technology apart is its rare dual application. The proprietary PlaCCine platform is a non-viral DNA technology being developed to target both infectious diseases and oncology ...

As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in coming days, analysts and especially investors will keep their eyes on whether the ...